Statistics

Total Visits

Views
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice33

Select a period of time:

Number of views in the range

Views
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice11

Views

Views
September 20251
October 20252
November 20251
December 20251
January 20260
February 20261
March 20265
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Argentina1
Costa Rica1
Finland1
Mexico1
 

Top cities views

Views
Spokane2
San Jose2
Dallas1
Helsinki1
Mendoza1
San José1
Zapopan1